Efficacy and safety of weekly versus triweekly cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma: A meta-analysis

Cisplatin-based concurrent chemoradiotherapy is a standard of care for locally advanced nasopharyngeal carcinoma (NPC), and weekly and triweekly cisplatin are both alternative regimens based on the results of squamous cell carcinoma of the head and neck. However, there is a lack of direct evidence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Long, Li, Yi-Chang, Hu, Min, Zhao, Shi-Jie, Yang, Qiang-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803506/
https://www.ncbi.nlm.nih.gov/pubmed/36596073
http://dx.doi.org/10.1097/MD.0000000000031842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803506/
https://www.ncbi.nlm.nih.gov/pubmed/36596073
http://dx.doi.org/10.1097/MD.0000000000031842

Ejemplares similares